6月19日，为期三天的CPHI（世界制药原料中国展）在中国上海开幕，AHA国际携手华谊药业共同参展，展示W2P02。
中国医药产业在全球医药产业价值链中占据重要地位，作为医药行业国际贸易领军企业，AHA国际和华谊药业以特色国际贸易与高端药品研发制造双翼发展模式吸引了众多国内外客户及合作伙伴莅临展位洽谈。
本次展会由AHA国际有限公司董事长梁庆带队，与华谊药业董事长高宇、AHA国际副总裁余令敏、副总裁兼食品配料事业部总经理姜业龙、副总裁王云峰、总裁助理兼医药事业部总经理王启壮、营养健康事业部总经理李媛媛等一起，就客户感兴趣的产品和服务进行了探讨。
大健康领域是AHA国际贸易的特色业务之一，经过多年的探索和深耕，逐渐形成了以药品、营养品、食品原料为主的产业链发展模式，其中药品是大健康领域的重要组成部分。AHA国际希望与国内外CDMO业务合作伙伴、生产商、经销商共同探讨医药贸易未来发展，推动医疗模式医药贸易转型，打造医药贸易一体化服务品牌。
A.H.A International Co., Ltd has over 40 years of professional foreign trade experience and resources has multiple franchise qualifications, and has passed multiple international certifications such as AEO, ISO, Ecovadis, etc. Relying on a professional business team, we aim to create one-stop foreign trade solutions such as “marketing, regulatory support, business operations, logistics support, and after-sales service”. Through the continuous accumulation of professional resources and experience in research and development, production, and registration, we continuously explore providing professional and reliable integrated pharmaceutical CDMO operation solutions for domestic and foreign manufacturers, distributors, and partners. The company’s trade scope covers nearly 100 countries and regions, with nearly 1000 cooperative suppliers, operating nearly 1000 types of goods, and an average annual export of over 4000 standard containers. Establish overseas operating companies in key trade areas to provide customers with warehousing and localization services.